Vector Laboratories

16 articles with Vector Laboratories

• Vector Laboratories Launches Glysite™ Scout Glycan Screening Kits to Progress Glycobiology Research

  7/19/2022

  Vector Laboratories , the pioneer of innovative proteomic and glycomic solutions, today announced the launch of its novel product Glysite™ Scout Glycan Screening Kits.

• Vector Laboratories Adds Kum Ming Woo to Executive Team as Vice President, Operations

  3/29/2022

  Vector Laboratories today announced that Kum Ming Woo has joined its executive team as Vice President, Operations.

• Vector Laboratories Selects Newark, CA for New Corporate Headquarters

  3/16/2022

  Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, opened its new facility in Newark, California, where it will relocate its corporate headquarters this year.

• Vector Laboratories Adds Katy Miles to its Board

  2/2/2022

  Vector Laboratories today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022.

• Mike Morales Joins Vector Laboratories as Chief Financial Officer

  12/14/2021

  Mr. Morales' decades of financial experience in the life sciences sector will drive Vector Laboratories' ongoing expansion strategy.

• 

  BioSpace Movers & Shakers, Nov. 19

  11/19/2021

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Vector Laboratories Elevates Pamela James to Vice President, Product on Executive Team

  11/16/2021

  Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has promoted Pamela James, Ph.D., to the position of Vice President, Product, effective immediately.

• Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express

  9/7/2021

  Vector Laboratories today announced that it has closed a $124 million cash buyout, backed by private equity firm Thompson Street Capital Partners to accelerate its expansion into protein detection.

• Vector Laboratories Attains ISO 9001:2015 Certification

  11/14/2018

  This new designation for the company certifies a high level of quality assurance and consistency.

• New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications 

  9/11/2018

  Vector Laboratories introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

• Advanced Immunolabeling Reagents and Tools From Vector Laboratories Now from Bio-Techne

  1/15/2018

  Several reagents from Vector Laboratories are currently available at novusbio.com for distribution within the continental U.S.

• Vector Labs Introduces First Effective Reagent for Autofluorescence Quenching

  11/14/2017

  TrueVIEW is effective across the spectral range from blue to far red and is compatible with commonly used fluorophores.

• Vector Laboratories Publishes New Guide for Immunofluorescence

  10/20/2017

  Vector Laboratories a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of a new guide for the growing field of immunofluorescence (IF).

• Vector Laboratories, Inc. Release: New Polymer Kit Enables IHC Staining Of Two Target Antigens In One Protocol

  10/4/2017

• Vector Laboratories, Inc. Names NeoBioscience Exclusive Distributor For China

  9/28/2017

• Vector Laboratories, Inc. Release: New Double-Staining Kit Streamlines Immunofluorescence Workflow

  9/8/2017